Stocks
PerkinElmer, Inc.PKI
NYSEHealthcareDiagnostics & Research$115.24-0.91%
A global leader in diagnostics, life sciences, and applied services, PerkinElmer provides analytical instruments, reagents, and software to pharmaceutical, biotechnology, and environmental markets. Investors monitor its performance due to its exposure to high-growth areas like genetic screening and drug discovery tools. The company's recent spin-off of its lower-margin businesses has sharpened its focus on higher-value healthcare and life sciences solutions.
Market Cap: $14.5B52W Range: $113.17 – $170.00
Congressional Interest in PerkinElmer, Inc. (PKI)
9 members of Congress have disclosed 34 trades in PerkinElmer, Inc. (PKI), a Healthcare company. The buy/sell breakdown shows 9 purchases versus 25 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
34
Unique Politicians
9
Buys
9
Sells
25
Who in Congress Is Trading PKI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-09-23 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-11-21 | Gilbert Cisneros | buy | $1K – $15K |